PPD hires new head of clinical development in Asia
This article was originally published in Scrip
The CRO PPD has appointed Edward Ian as vice-president of clinical development for Asia Pacific. Mr Ian will be based in Singapore and will provide strategic leadership and operational oversight for PPD's Phase II-IV business in the region. He spent six years at rival CRO PRA, where he served as executive director of scientific affairs responsible for Phase I-IV clinical operations in Asia Pacific. He began his career as a laboratory scientist and later served as director of business development and quality assurance for a regional CRO in Taiwan, where he rose to executive vice-president.
You may also be interested in...
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"